Audioscenic – the UK-based audio technology innovator – has appointed John Croteau, a veteran technology executive, as Chairman of its Board of Directors.
Croteau brings an impressive track record of driving innovation and growth in the tech sector including his roles as GM at Analog Devices, Senior VP at NXP, CEO at MACOM, and currently as CEO at neural biosensor company Pison. Croteau’s strategic guidance will be instrumental in steering Audioscenic through its next phase of technological advancement, innovation, and product integrations.
Croteau’s career is marked by his ability to drive technological innovation and business growth. At Pison Technology, Croteau leads groundbreaking advancements in neural biosensing in smartwatches for mental health, wellness, and cognitive performance applications.
Before Pison, he served as CEO of MACOM, a supplier of semiconductor solutions, where he oversaw the company’s expansion into new markets and spearheaded the development of cutting-edge semiconductor technologies, transforming the company into a high-growth business. During Croteau’s 24-year tenure at semiconductor icon Analog Devices, he rose up the ranks from Product Marketing Engineer to leading a portfolio of business units spanning consumer, industrial, military and automotive markets.
Croteau commented: “I am thrilled to join Audioscenic at such a defining moment in the company’s evolution. With its innovative, position-adaptive 3D sound technology, Audioscenic is well-positioned to capitalise on the industry’s secular growth in immersive, 3D content. I look forward to collaborating with this talented team of forward-thinkers, leveraging their extensive R&D expertise to drive strategic growth, strengthen our market presence, and deliver transformative audio experiences to consumers around the world.”
As Chairman, Croteau will focus on strategy, innovation, and expanding Audioscenic’s market presence. His deep understanding of the technology landscape and his proven track record of successful leadership will be invaluable assets to the company.
